PKCδ-dependent Activation of the Ubiquitin Proteasome System is Responsible for High Glucose-induced Human Breast Cancer MCF-7 Cell Proliferation, Migration and Invasion |
Zhu, Shan
(Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University)
Yao, Feng (Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University) Li, Wen-Huan (Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University) Wan, Jin-Nan (Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University) Zhang, Yi-Min (Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University) Tang, Zhao (Department of Pathology and Pathophysiology, Wuhan University School of Basic Medical Sciences) Khan, Shahzad (Department of Pathology and Pathophysiology, Wuhan University School of Basic Medical Sciences) Wang, Chang-Hua (Department of Pathology and Pathophysiology, Wuhan University School of Basic Medical Sciences) Sun, Sheng-Rong (Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University) |
1 | Sasaki S, Inoguchi T (2012). The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab J, 36, 255-61. DOI ScienceOn |
2 | Warburg, O (1956). On the origin of cancer cells. Science, 123, 309-14. DOI |
3 | Sato K, Rajendra E, Ohta T (2008). The UPS: a promising target for breast cancer treatment. BMC Biochem, 9, S2. DOI ScienceOn |
4 | Smith HJ, Wyke SM, Tisdale MJ (2004). Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes. Br J Cancer, 90, 1850-7. |
5 | Srivastava AK (2002). High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review). Int J Mol Med, 9, 85-9. |
6 | Wing SS (2008). The UPS in diabetes and obesity. BMC Biochem, 9, S6. DOI ScienceOn |
7 | Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005). Diabetes mellitus and breast cancer. Lancet Oncol, 6, 103-11. DOI ScienceOn |
8 | Wu WK, Cho CH, Lee CW, et al (2010). Proteasome inhibition: a new therapeutic strategy to cancer treatment. Cancer Lett, 293, 15-22. DOI ScienceOn |
9 | Wu WS (2006). The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev, 25, 695-705. |
10 | Ciechanover A, Orian A, Schwartz AL (2000). Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays, 22, 442-51. DOI |
11 | Ciechanover A, Schwartz AL (1994). The ubiquitin-mediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB J, 8, 182-91. |
12 | Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004). Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol, 159, 1160-7. DOI ScienceOn |
13 | Driscoll JJ, Woodle ES (2012). Targeting the ubiquitin+proteasome system in solid tumors. Semin Hematol, 49, 277-83. DOI ScienceOn |
14 | Cvek B, Dvorak Z (2011). The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomib. Curr Pharm Des, 17, 1483-99. DOI ScienceOn |
15 | Dang CV, Semenza GL (1999). Oncogenic alterations of metabolism. Trends Biochem Sci, 24, 68-72. DOI ScienceOn |
16 | Dees EC, Orlowski RZ (2006). Targeting the ubiquitin-proteasome pathway in breast cancer therapy. Future Oncol, 2, 121-35. DOI ScienceOn |
17 | Goldberg AL (2003). Protein degradation and protection against misfolded or damaged proteins. Nature, 426, 895-9. DOI ScienceOn |
18 | Grossoni VC, Falbo KB, Kazanietz MG, de Kier Joffe ED, Urtreger AJ (2007). Protein kinase C delta enhances proliferation and survival of murine mammary cells. Mol Carcinog, 46, 381-90. DOI ScienceOn |
19 | Bence NF, Sampat RM, Kopito RR (2001). Impairment of the ubiquitin-proteasome system by protein aggregation. Science, 292, 1552-5. DOI ScienceOn |
20 | Bugliani M, Liechti R, Cheon H, et al (2013). Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin-proteasome system in pancreatic beta cell dysfunction. Mol Cell Endocrinol, 367, 1-10. DOI ScienceOn |
21 | Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE (2011). Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov, 10, 29-46. DOI ScienceOn |
22 | Kiley SC, Clark KJ, Duddy SK, Welch DR, Jaken S (1999). Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression. Oncogene, 18, 6748-57. DOI |
23 | Hauptmann S, Grunewald V, Molls D, et al (2005). Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation. Anticancer Res, 25, 3431-6. |
24 | Hochstrasser M (1995). Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol, 7, 215-23. DOI ScienceOn |
25 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
26 | Kirk-Ballard H, Wang ZQ, Acharya P, et al (2013). An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes. PLoS One, 8, e57112. DOI ScienceOn |
27 | Kroemer G, Pouyssegur J (2008). Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell, 13, 472-82. DOI ScienceOn |
28 | Landis-Piwowar KR, Milacic V, Chen D, et al (2006). The proteasome as a potential target for novel anticancer drugs and chemosensitizers. Drug Resist Updat, 9, 263-73. DOI ScienceOn |
29 | Liao S, Li J, Wang L, et al (2010). Type 2 diabetes mellitus and characteristics of breast cancer in China. Asian Pac J Cancer Prev, 11, 933-7. |
30 | Larsson SC, Mantzoros CS, Wolk A (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 121, 856-62. DOI ScienceOn |
31 | Liao S, Li J, Wei W, et al (2011). Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev, 12, 1061-5. |
32 | Masur K, Vetter C, Hinz A, et al (2011). Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer, 104, 345-52. DOI ScienceOn |
33 | Marfella R, Di Filippo C, D'Amico M, Paolisso G (2007). Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture. Circ Res, 100, e84-5. DOI ScienceOn |
34 | Marfella R, Di Filippo C, Portoghese M, et al (2009). The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol, 18, 332-45. DOI ScienceOn |
35 | Micel LN, Tentler JJ, Smith PG, Eckhardt GS (2013). Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J Clin Oncol, 31, 1231-8. DOI ScienceOn |
36 | Orlowski RZ, Dees EC (2003). The role of the ubiquitination-proteasome pathway in breast cancer: applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer. Breast Cancer Res, 5, 1-7. DOI ScienceOn |
37 | Rubinsztein DC (2006). The roles of intracellular protein-degradation pathways in neurodegeneration. Nature, 443, 780-6. DOI ScienceOn |
38 | Gillies RJ, Gatenby RA (2007). Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr, 39, 251-7. DOI |
39 | Liu Z, Miers WR, Wei L, Barrett EJ (2000). The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes. Biochem Biophys Res Commun, 276, 1255-60. DOI ScienceOn |
40 | Naujokat C, Berges C, Hoh A, et al (2007). Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Immunology, 120, 120-32. |